Cadavedo, Ian Rose .
HRN: 14-28-34 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/19/2022
AMPICILLIN 1GM (VIAL)
09/19/2022
09/25/2022
IV
2 G
Q6
Post Term
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes